A perspective on the contribution of animal models to the pharmacological treatment of posttraumatic stress disorder

作者：Bertaina Anglade Valerie; O'Connor Susan M; Andriambeloson Emile

来源：Australasian Psychiatry, 2017, 25(4): 342-347.

DOI：10.1177/1039856217716288

<jats:sec><jats:title>Objectives:</jats:title><jats:p> Posttraumatic stress disorder (PTSD) is a prevalent, chronic, disabling disorder that may develop following exposure to a traumatic event. This review summarizes currently used animal models of PTSD and their potential role in the development of better therapeutics. Heterogeneity is one of the main characteristics of PTSD with the consequence that many pharmacological approaches are used to relieve symptoms of PTSD. To address the translational properties of the animal models, we discuss the types of stressors used, the rodent correlates of human PTSD (DSM-5) symptoms, and the efficacy of approved, recommended and off-label drugs used to treat PTSD in ‘PTSD-animals’. </jats:p></jats:sec><jats:sec><jats:title>Conclusions:</jats:title><jats:p> Currently available animal models reproduce most PTSD symptoms and are validated by existing therapeutics. However, novel therapeutics are needed for this disorder as not one drug alleviates all symptoms and many have side effects that lead to non-compliance among PTSD patients. The true translational power of animal models of PTSD will only be demonstrated when new therapeutics acting through novel mechanisms become available for clinical practice. </jats:p></jats:sec>

• 出版日期2017-8